Full Text View
Tabular View
No Study Results Posted
Related Studies
Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00753207   Information provided by National Cancer Institute (NCI)
First Received: September 13, 2008   Last Updated: February 11, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
epirubicin hydrochloride
lapatinib ditosylate
biomarker analysis
liquid chromatography
mass spectrometry
Additional drug interventions recognized in this trial
Epirubicin
Lapatinib
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Irish Clinical Oncology Research Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services